AMSA Pharm-free Scorecard 2010
A University of Michigan Medical School
City: Ann Arbor State: MI
Commentary:

The University of Michigan Medical School has many model policies in place. This year, they have submitted new policies that have resulted in increases in the domains for on-site medical education and gifts.  Both of these domains now represent model policies.  In regards to gifts, all gifts are probited regardless of value.  On-site education has strict limitations in place, which does not allow for industry funding of CME.In addition, they have a comprehensive disclosure system with plans for a public disclosure website.  Lack of a policy on industry funded scholarships is surprising, in comparison to peers, and there are signs that one is being developed, although none has been supplied to AMSA for review. This school's policy was evaluated after the release of the 2011-12 Scorecard.  

 

Updates:

This institution submitted new policies for review for the 2012-3 AMSA PharmFree Scorecard.

 

This institution's evaluation was last updated: 4/9/2013. 



Gifts & Meals 3 Gifts and on-site meals are prohibited from being directly supplied by vendors. Gifts, regardless of value, are prohibited.
Consulting relationships 3 "Outside Interest disclosures occur annually and must be updated during the year should circumstances change or new Outside Interests arise… [Disclosures will be] assessed for… level of compensation to ensure it is commensurate with the effort."
Industry-funded speaking relationships 3 Faculty and staff are prohibited from participating in speakers' bureaus unless approved by the CECOI committee.
Disclosure 2 This school has implemented mandatory disclosure of all financial COI to all students, either verbally or in writing. There is no public disclosure at this time, but there are plans for a publicly accessible website. Upon its launch, this policy would become a model policy.
Pharmaceutical samples 3 The Medical School institutes model language on samples.

The policy acknowledges that samples are primarily marketing tools for the drug industry and bans them as such, with a narrow exception for special circumstances, which may be petitioned to the Ambulatory Formulary Committee and Site Medical Director.  

Further, recognizing their functions of convenience and value to patients, the institution distributes pharmaceutical vouchers through Pharmacy Services for complimentary starter medications of formulary drugs at a patient's chosen pharmacy -   breaking the link between sales representatives and physicians, as well as eliminating the safety risks inherent with unregulated sample distribution.
Purchasing & Formularies 3 The institution establishes a choice of methods for mitigating conflict of interest in committee decisions, but all require that the individual with conflict recuse him or herself from voting.
Industry Sales Representatives 2 Vendors are allowed on campus by appt, but are restricted to non-patient care areas except for device and product training, and then only with approval.
On-campus Education 3 They do not accept industry funding for CME.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 2 The gifts/meals ban covers gifts and meals for off-site events, but it is not clear from policies provided whether travel and attendance costs are covered by it, as well.
Industry Support for Scholarships & Funds for Trainees 1 The Medical School indicates that a new policy on scholarship/trainee funds is in development.
Medical school curriculum 3 The Medical School provided materials for course curriculum, "Drug Development, Marketing and Industry Relationships" for first and second year medical students.
Do the policies specify an oversight mechanism? Yes This policy makes it clear that departments are responsible for oversight, with more broad oversight by the Conflict of Interest Board.
Are there explicit sanctions for noncompliance? Yes There are clear sanctions for noncompliance.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)